13-110186299-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.1897+86T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,551,680 control chromosomes in the GnomAD database, including 355,746 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 34723 hom., cov: 33)
Exomes 𝑓: 0.68 ( 321023 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.531

Publications

11 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-110186299-A-G is Benign according to our data. Variant chr13-110186299-A-G is described in ClinVar as Benign. ClinVar VariationId is 1249954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.694 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.1897+86T>C intron_variant Intron 26 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.1897+86T>C intron_variant Intron 26 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.674
AC:
102534
AN:
152016
Hom.:
34681
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.665
Gnomad AMI
AF:
0.735
Gnomad AMR
AF:
0.704
Gnomad ASJ
AF:
0.612
Gnomad EAS
AF:
0.530
Gnomad SAS
AF:
0.602
Gnomad FIN
AF:
0.733
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.684
Gnomad OTH
AF:
0.640
GnomAD4 exome
AF:
0.675
AC:
945079
AN:
1399544
Hom.:
321023
AF XY:
0.673
AC XY:
470613
AN XY:
699264
show subpopulations
African (AFR)
AF:
0.668
AC:
21567
AN:
32292
American (AMR)
AF:
0.754
AC:
33610
AN:
44564
Ashkenazi Jewish (ASJ)
AF:
0.585
AC:
15043
AN:
25706
East Asian (EAS)
AF:
0.519
AC:
20430
AN:
39330
South Asian (SAS)
AF:
0.621
AC:
52268
AN:
84196
European-Finnish (FIN)
AF:
0.733
AC:
38268
AN:
52182
Middle Eastern (MID)
AF:
0.528
AC:
2135
AN:
4046
European-Non Finnish (NFE)
AF:
0.683
AC:
723355
AN:
1059038
Other (OTH)
AF:
0.660
AC:
38403
AN:
58190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
15150
30299
45449
60598
75748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18144
36288
54432
72576
90720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.675
AC:
102641
AN:
152136
Hom.:
34723
Cov.:
33
AF XY:
0.676
AC XY:
50221
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.665
AC:
27617
AN:
41504
American (AMR)
AF:
0.705
AC:
10780
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.612
AC:
2122
AN:
3470
East Asian (EAS)
AF:
0.530
AC:
2728
AN:
5146
South Asian (SAS)
AF:
0.604
AC:
2912
AN:
4822
European-Finnish (FIN)
AF:
0.733
AC:
7768
AN:
10598
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.684
AC:
46530
AN:
67986
Other (OTH)
AF:
0.642
AC:
1355
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1779
3557
5336
7114
8893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
816
1632
2448
3264
4080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.673
Hom.:
61830
Bravo
AF:
0.672
Asia WGS
AF:
0.575
AC:
2002
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.87
DANN
Benign
0.22
PhyloP100
-0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs565470; hg19: chr13-110838646; COSMIC: COSV65433787; COSMIC: COSV65433787; API